Shree Ganesh Biotech shareholders approve FY26 accounts, re-appoint Patel
- Shareholders adopted FY26 audited financial statements with 94.90% votes in favor
- Aman Patel re-appointed as director with 94.77% support from polled votes
- Total votes polled across both resolutions stood at 6,740,997
- AGM held on September 28, 2026, at registered office in Kolkata

*this image is generated using AI for illustrative purposes only.
Shree Ganesh Biotech (India) Limited shareholders adopted the audited financial statements for the fiscal year ended March 31, 2026, during the company's 16th Annual General Meeting (AGM). The meeting, held on September 28, 2026, also saw the re-appointment of Aman Patel as a director retiring by rotation.
The AGM commenced at 3:00 pm and concluded at 3:30 pm at the company's registered office in Kolkata. All proposed resolutions were passed by the shareholders present at the meeting. Voting results indicate strong support for both agenda items, with approximately 95% of polled votes cast in favor.
Key resolutions and voting outcomes
The following ordinary resolutions were transacted and approved by the shareholders:
- Adoption of FY26 financials: The audited financial statements for FY26, along with the reports of the Directors and Auditors, were adopted. A total of 6,740,997 votes were polled on this resolution. Of these, 6,397,489 votes were in favor (94.90%) and 343,508 were against (5.10%).
- Re-appointment of Director: Aman Patel (DIN: 08483544) was re-appointed as a director retiring by rotation. The same number of total votes (6,740,997) was polled, with 6,388,669 votes in favor (94.77%) and 352,328 against (5.23%).
The voting process included both remote e-voting and physical poll facilities. For the financial statements adoption, 192 members voted in favor via e-voting, while 1 member voted in favor via poll. For the director's re-appointment, 186 members voted in favor via e-voting, and 1 via poll.
Compliance and meeting details
The proceedings were conducted in compliance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Details regarding the voting results, as required under Regulation 44(3) of the Listing Regulations, were submitted separately to the stock exchanges.
| Event | Date | Time | Location |
|---|---|---|---|
| 16th Annual General Meeting | September 28, 2026 | 3:00 pm - 3:30 pm | Registered Office, Kolkata |
The filing was signed by Aman Patel, Whole-Time Director, confirming the outcome of the meeting. The scrutinizer's report, prepared by Daksha Negi & Associates, confirmed that no invalid or incomplete votes were found in the e-voting system.
Historical Stock Returns for Shree Ganesh Bio-Tech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.13% | -4.17% | -8.00% | -16.36% | -40.26% | 0.0% |
How does Shree Ganesh Biotech's FY26 financial performance compare to its FY25 results and industry peers?
What specific strategic initiatives or capital expenditure plans were outlined in the Director's Report adopted during the AGM?
Will the re-appointment of Aman Patel lead to any changes in the company's governance structure or operational leadership?
































